FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885748118> ?p ?o ?g. }

• W2885748118 endingPage "102" @default.
• W2885748118 startingPage "96" @default.
• W2885748118 abstract "Background— The Dual Antiplatelet Therapy Study is large streamlined clinical trial designed to evaluate antiplatelet treatment strategies in a broadly inclusive population of subjects treated with coronary stents. Whether large streamlined trials can successfully include a representative group of study sites and patients has not been formally assessed. Methods and Results— Within the National Cardiovascular Data Registry CathPCI Registry, we compared characteristics and outcomes of hospitals participating versus not participating in the Dual Antiplatelet Therapy Study. We also compared clinical and procedural characteristics of trial subjects undergoing percutaneous coronary intervention (PCI) with drug-eluting stents to contemporaneous patients within the National Cardiovascular Data Registry CathPCI Registry. Standardized differences between groups were estimated. Between September 2009 and July 2011, 1.1 million PCIs were performed among 1276 hospitals, of which 309 (24.2%) participated in the Dual Antiplatelet Therapy Study. Participating hospitals were larger (468 versus 311 beds), more frequently located in urban settings (61.2% versus 42.6%), and had higher annual PCI volumes (858 versus 378) compared with nonparticipating hospitals, although hospital case mix and procedural outcomes were similar. Compared with CathPCI patients, trial patients undergoing PCI with drug-eluting stents were similar with respect to race, sex, and rates of diabetes mellitus, hypertension, and smoking, although they had lower rates of prior cardiovascular disease. Conclusions— Within the Dual Antiplatelet Therapy Study, clinical trial sites had similar patient case mix and clinical outcomes as nonparticipating sites. Although trial participants were representative of PCI patients with respect to race, sex and most comorbidities, they had a lower prevalence of chronic cardiovascular disease compared with registry patients. Although a streamlined cardiovascular clinical trial may successfully involve a large number of hospitals and rapidly enroll a diverse population of patients, differences between eligible patients and those actually enrolled remained. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00977938." @default.
• W2885748118 created "2018-08-22" @default.
• W2885748118 creator A5004967840 @default.
• W2885748118 creator A5027110367 @default.
• W2885748118 creator A5040994851 @default.
• W2885748118 creator A5046396861 @default.
• W2885748118 creator A5048447382 @default.
• W2885748118 creator A5055866744 @default.
• W2885748118 creator A5061963775 @default.
• W2885748118 creator A5072881675 @default.
• W2885748118 creator A5078888395 @default.
• W2885748118 creator A5081743465 @default.
• W2885748118 creator A5082003758 @default.
• W2885748118 creator A5089120659 @default.
• W2885748118 date "2015-01-01" @default.
• W2885748118 modified "2023-10-18" @default.
• W2885748118 title "Evaluating the Generalizability of a Large Streamlined Cardiovascular Trial" @default.
• W2885748118 cites W177659041 @default.
• W2885748118 cites W2007904232 @default.
• W2885748118 cites W2009899617 @default.
• W2885748118 cites W2015712245 @default.
• W2885748118 cites W2027943065 @default.
• W2885748118 cites W2042104538 @default.
• W2885748118 cites W2043254260 @default.
• W2885748118 cites W2049491523 @default.
• W2885748118 cites W2054371281 @default.
• W2885748118 cites W2060521891 @default.
• W2885748118 cites W2068802228 @default.
• W2885748118 cites W2076602637 @default.
• W2885748118 cites W2086890457 @default.
• W2885748118 cites W2103345184 @default.
• W2885748118 cites W2110444897 @default.
• W2885748118 cites W2116103373 @default.
• W2885748118 cites W2121283374 @default.
• W2885748118 cites W2121908294 @default.
• W2885748118 cites W2125855951 @default.
• W2885748118 cites W2154365079 @default.
• W2885748118 cites W2158092781 @default.
• W2885748118 cites W2169490447 @default.
• W2885748118 cites W2315376359 @default.
• W2885748118 cites W2333929093 @default.
• W2885748118 cites W53719006 @default.
• W2885748118 cites W75302244 @default.
• W2885748118 doi "https://doi.org/10.1161/circoutcomes.114.001239" @default.
• W2885748118 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4303486" @default.
• W2885748118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25399847" @default.
• W2885748118 hasPublicationYear "2015" @default.
• W2885748118 type Work @default.
• W2885748118 sameAs 2885748118 @default.
• W2885748118 citedByCount "20" @default.
• W2885748118 countsByYear W28857481182014 @default.
• W2885748118 countsByYear W28857481182015 @default.
• W2885748118 countsByYear W28857481182016 @default.
• W2885748118 countsByYear W28857481182017 @default.
• W2885748118 countsByYear W28857481182018 @default.
• W2885748118 countsByYear W28857481182019 @default.
• W2885748118 countsByYear W28857481182020 @default.
• W2885748118 countsByYear W28857481182021 @default.
• W2885748118 countsByYear W28857481182022 @default.
• W2885748118 crossrefType "journal-article" @default.
• W2885748118 hasAuthorship W2885748118A5004967840 @default.
• W2885748118 hasAuthorship W2885748118A5027110367 @default.
• W2885748118 hasAuthorship W2885748118A5040994851 @default.
• W2885748118 hasAuthorship W2885748118A5046396861 @default.
• W2885748118 hasAuthorship W2885748118A5048447382 @default.
• W2885748118 hasAuthorship W2885748118A5055866744 @default.
• W2885748118 hasAuthorship W2885748118A5061963775 @default.
• W2885748118 hasAuthorship W2885748118A5072881675 @default.
• W2885748118 hasAuthorship W2885748118A5078888395 @default.
• W2885748118 hasAuthorship W2885748118A5081743465 @default.
• W2885748118 hasAuthorship W2885748118A5082003758 @default.
• W2885748118 hasAuthorship W2885748118A5089120659 @default.
• W2885748118 hasBestOaLocation W28857481181 @default.
• W2885748118 hasConcept C105795698 @default.
• W2885748118 hasConcept C126322002 @default.
• W2885748118 hasConcept C134018914 @default.
• W2885748118 hasConcept C168563851 @default.
• W2885748118 hasConcept C1862650 @default.
• W2885748118 hasConcept C194828623 @default.
• W2885748118 hasConcept C27158222 @default.
• W2885748118 hasConcept C2778213512 @default.
• W2885748118 hasConcept C2778959093 @default.
• W2885748118 hasConcept C2779134260 @default.
• W2885748118 hasConcept C2780400711 @default.
• W2885748118 hasConcept C2908647359 @default.
• W2885748118 hasConcept C33923547 @default.
• W2885748118 hasConcept C45393284 @default.
• W2885748118 hasConcept C500558357 @default.
• W2885748118 hasConcept C535046627 @default.
• W2885748118 hasConcept C555293320 @default.
• W2885748118 hasConcept C71924100 @default.
• W2885748118 hasConcept C99454951 @default.
• W2885748118 hasConceptScore W2885748118C105795698 @default.
• W2885748118 hasConceptScore W2885748118C126322002 @default.
• W2885748118 hasConceptScore W2885748118C134018914 @default.
• W2885748118 hasConceptScore W2885748118C168563851 @default.
• W2885748118 hasConceptScore W2885748118C1862650 @default.
• W2885748118 hasConceptScore W2885748118C194828623 @default.

• next